Healthcare - Press Releases

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination. The market growth is largely fueled by the increasing uptake of the influenza vaccine and government efforts to raise awareness and encourage vaccination.

Enhanced Women's Health Program Integrates Pelvic Floor Therapy and Menopause Care Through Partnership with Vira Health

FREMONT, Calif., Feb. 20, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of its Certified Service Provider (CSP) Program, designed to expand access to its cutting-edge NULISA assays in academia and biopharmaceutical research.

WINDHAM, N.H., Feb. 20, 2025 /PRNewswire/ --The United States is projected to face a shortage of up to 8,650 cardiologists by 2037, raising serious concerns about access to cardiovascular care. To help healthcare leaders navigate the growing workforce challenge, Medicus Healthcare Solutions has released a new white paper titled An Inside Look at the Cardiology Workforce: Shortages, Demand, and Strategic Responses.

HONG KONG, Feb. 20, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced the company has successfully enrolled the first patient in itsmulticenter, randomized, double-blind Phase III clinical trial of ivonescimab in combination with chemotherapy for first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) (HARMONi-BC1/AK112-308). Ivonescimab is a first-in-class PD-1/VEGF bispecific antibody independently developed by the company.

Auf dem 25. Wellness Congress stellte Nerio Alessandri in Anwesenheit von 2.000 Menschen aus 100 Lndern Healthness vor, die neue Vision, die die Zukunft von Wellness und Prvention revolutionieren wird.

LUND,Sweden, Feb. 21, 2025 /PRNewswire/ --Immunovia will publish its full year 2024 results on February 25, 2025 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com.

Bracco will present an immersive experience at its booth to educate congress attendees on the importance of corporate commitment to sustainability and how its MR imaging portfolio contributes to the progress of sustainable radiology.

Bracco Diagnostics Inc. (PRNewsFoto/Bracco Diagnostics Inc.) (PRNewsfoto/Bracco Group)

STOCKHOLM, Feb. 21, 2025 /PRNewswire/ -- SciBase Holding AB("SciBase") (STO: SCIB),a leading developer of augmented intelligence-based solutions for skin disordersannounced today, that an article comparing US and German dermatologists improved biopsy decisions following the addition of Nevisense (EIS) as a decision support tool was recently published in SKIN, the Journal of Cutaneous Medicine. The article compares two corresponding studies, one conducted in the US and one in Germany, with the aim to evaluate how Nevisense (EIS) impacted dermatologist's biopsy decisions. The findings were that for both groups the addition of dermoscopy and even more so Nevisense (EIS) as decision support tools significantly improved biopsy decision accuracy. Findings revealed that American dermatologists had a higher rate of correct biopsy decisions for malignant melanomas (MMs) compared to their German counterparts. However, German dermatologists showed greater accuracy in avoiding unnecessary biopsies of benign pigmented skin lesions.

HELLERUP,Denmark, Feb. 21, 2025 /PRNewswire/ -- UNION therapeutics A/S (UNION), a privately-held, clinical stage, pharmaceutical development company focused on immunology, today announced a poster presentation on new clinical data of oral orismilast in patients with UC at the 20thEuropean Crohn's and Colitis Organisation (ECCO) congress on February 19-22, 2025, in Berlin, Germany.

HELLERUP,Denmark, Feb. 21, 2025 /PRNewswire/ -- UNION therapeutics A/S (UNION), a privately-held, clinical stage, pharmaceutical development company focused on immunology, today announced a poster presentation on new clinical data of oral orismilast in patients with UC at the 20thEuropean Crohn's and Colitis Organisation (ECCO) congress on February 19-22, 2025, in Berlin, Germany.

STOCKHOLM, Feb. 21, 2025 /PRNewswire/ -- SciBase Holding AB("SciBase") (STO: SCIB),a leading developer of augmented intelligence-based solutions for skin disordersannounced today, that an article comparing US and German dermatologists improved biopsy decisions following the addition of Nevisense (EIS) as a decision support tool was recently published in SKIN, the Journal of Cutaneous Medicine. The article compares two corresponding studies, one conducted in the US and one in Germany, with the aim to evaluate how Nevisense (EIS) impacted dermatologist's biopsy decisions. The findings were that for both groups the addition of dermoscopy and even more so Nevisense (EIS) as decision support tools significantly improved biopsy decision accuracy. Findings revealed that American dermatologists had a higher rate of correct biopsy decisions for malignant melanomas (MMs) compared to their German counterparts. However, German dermatologists showed greater accuracy in avoiding unnecessary biopsies of benign pigmented skin lesions.

LEHI, UT. and LOUISVILLE,KY., Feb. 20, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the "Selling Stockholders") at a price to the public of $40.00 per share. Additionally, the Selling Stockholders have granted the underwriters a 30-day option to purchase up to 3,000,000 additional shares of common stock.Waystar is not selling any shares and will not receive any proceeds from the sale of shares in the offering by the Selling Stockholders. The offering is expected to close on or about February 24, 2025, subject to customary closing conditions.

STOCKHOLM, Feb. 21, 2025 /PRNewswire/ --

- En el 25 Congreso de Bienestar, ante 2.000 personas de 100 pases, Nerio Alessandri lanz Healthness, la nueva visin que revolucionar el futuro del bienestar y la prevencin

Global Financial Market Review (GFM) is a dedicated online news aggregation portal specializing in financial market news and industry updates. It combines original editorials with curated content from global news providers, reaching over 14 million readers annually. With a focus on reliability and depth, GFM has positioned itself as a trusted source in the financial sector, boasting a strong social media presence with over 180,000 Twitter followers.

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Compliancy Group, healthcare compliance tracking and management software, has been named toG2's 2025 Best Software Awards on the Healthcare Software Products list. G2's annual Best Software Awards rank the world's best software companies and products based on authentic, timely reviews from real users.

OSLO, Norway, Feb. 20, 2025 /PRNewswire/ -- In connection with the release of the results for the full year and fourth quarter 2024, Oncoinvent invites to the following events:

SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year2024 ended December 31, 2024, before the U.S. market opens on Thursday, March 20, 2025.

Global Financial Market Review (GFM) is a dedicated online news aggregation portal specializing in financial market news and industry updates. It combines original editorials with curated content from global news providers, reaching over 14 million readers annually. With a focus on reliability and depth, GFM has positioned itself as a trusted source in the financial sector, boasting a strong social media presence with over 180,000 Twitter followers.

Desert Senita

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong KongPharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving hundreds of millions of consumers. This partnership aims to revolutionize cross-border logistics services and enhance the overall customer experience.

The spinal cord injury market is expected to experience steady growth, with a strong CAGR of 15.4% forecast from 2024 to 2034. This growth across the 7MM will be propelled by the introduction of innovative therapies such as KP-100IT, Neuro-Cells, Elezanumab (ABT-555), and MT-3921.

Continan con sus esfuerzos para aumentar el acceso aopciones de tratamiento con insulina